Primary: To evaluate the efficacy of immersive virtual reality (VR) in reducing neuropathic pain (NP) in individuals with spinal cord injury (SCI).
Secondary: To assess the impact of immersive VR on depersonalization symptoms in the SCI population.
Design: Double-blind, randomized controlled trial.
Arch Phys Med Rehabil
March 2025
Study Design: Observational cohort.
Aim: To show that Cystatin C is an accurate single marker to estimate GFR in motor complete persons with SCI.
Objectives: To assess if Cystatin C is an accurate for estimating GFR in persons with SCI with no preserved motor power.